PASADENA, Calif.–(BUSINESS WIRE)– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the company will make presentations at the following upcoming events.
The 23rd Annual NewsMakers in the Biotech Industry – New York, September 9, 2016
September 9, 10:00 a.m. EDT – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate presentation
7th Non-Coding RNA & RNAi Therapeutics Conference – Boston, September 14-15, 2016
September 14, 4:30 p.m. EDT – Erik Bush, Ph.D., Arrowhead director of extrahepatic targeting will deliver an oral presentation titled, “Targeted delivery strategies using Dynamic PolyconjugateTM (DPCTM) technology”
2016 International HBV Meeting – Seoul, Korea, September 21-24, 2016
September 24, 8:30 a.m. KST – Zhao Xu, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Functional HBsAg-encoding HBV fusion transcripts are produced from integrated HBV DNA in chronically infected chimpanzees – evidence from single molecule, real time (SMRT) sequencing”